Page last updated: 2024-08-24

carbenoxolone sodium and Glaucoma, Suspect

carbenoxolone sodium has been researched along with Glaucoma, Suspect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheung, CM; Coca-Prados, M; Murray, PI; Rauz, S; Stewart, PM; Walker, EA; Wood, PJ	1

Trials

1 trial(s) available for carbenoxolone sodium and Glaucoma, Suspect

Article	Year
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM : monthly journal of the Association of Physicians, 2003, Volume: 96, Issue:7 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aged; Aqueous Humor; Carbenoxolone; Cortisone; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Intraocular Pressure; Male; Mineralocorticoid Receptor Antagonists; Ocular Hypertension; Prospective Studies; Receptors, Glucocorticoid	2003

Article

Year

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.

QJM : monthly journal of the Association of Physicians, 2003, Volume: 96, Issue:7

Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aged; Aqueous Humor; Carbenoxolone; Cortisone; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Intraocular Pressure; Male; Mineralocorticoid Receptor Antagonists; Ocular Hypertension; Prospective Studies; Receptors, Glucocorticoid

2003